Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Hepatocellular carcinoma as a disease tag and a new Genetic and Rare Diseases Information Center resource link. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check26 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3; no visible changes to the Study Details page.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision note v3.4.2 was added and older maintenance notes (v3.4.1) were removed, along with a government-funding status notice. This update affects only site metadata and does not alter study details or results.SummaryDifference0.4%

- Check62 days agoChange DetectedA site-wide notice about government funding lapses was added, and a new publication entry (Chan SL et al., Ann Hepatology, 2025) was added to the Publications section. An existing publication entry was revised to reflect the latest version.SummaryDifference0.5%

- Check69 days agoChange DetectedUI/text updates include a glossary toggle and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0; no changes to core study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedThe change appears to be a minor platform revision from v3.3.3 to v3.3.4. No study content or essential details (title, eligibility, outcomes, or locations) appear to be affected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.